NCT00697385View on ClinicalTrials.gov

The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
vonWillebrand DiseaseHemophiliaPlatelet Coagulation Disorders
Interventions
DRUG

Cyclokapron

(2) 500mg tablets taken by mouth every 6-8 hours

Trial Locations (1)

14621

Mary M. Gooley Hemophilia Center, Rochester

All Listed Sponsors
lead

Mary M. Gooley Hemophilia Center

OTHER

NCT00697385 - The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders | Biotech Hunter | Biotech Hunter